nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—Alzheimer's disease—amyotrophic lateral sclerosis	0.852	1	CtDrD
Rivastigmine—Motor dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00399	0.032	CcSEcCtD
Rivastigmine—Vestibular disorder—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0231	CcSEcCtD
Rivastigmine—Subdural haematoma—Riluzole—amyotrophic lateral sclerosis	0.00276	0.0221	CcSEcCtD
Rivastigmine—Peritonitis—Riluzole—amyotrophic lateral sclerosis	0.00229	0.0184	CcSEcCtD
Rivastigmine—BCHE—diaphragm—amyotrophic lateral sclerosis	0.00213	0.427	CbGeAlD
Rivastigmine—Rheumatoid arthritis—Riluzole—amyotrophic lateral sclerosis	0.00192	0.0154	CcSEcCtD
Rivastigmine—ACHE—Acetylcholine Synthesis—CHAT—amyotrophic lateral sclerosis	0.00176	0.0964	CbGpPWpGaD
Rivastigmine—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0124	CcSEcCtD
Rivastigmine—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0124	CcSEcCtD
Rivastigmine—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0122	CcSEcCtD
Rivastigmine—Hypochromic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00149	0.012	CcSEcCtD
Rivastigmine—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0113	CcSEcCtD
Rivastigmine—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0109	CcSEcCtD
Rivastigmine—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0109	CcSEcCtD
Rivastigmine—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0107	CcSEcCtD
Rivastigmine—Hernia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00989	CcSEcCtD
Rivastigmine—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00989	CcSEcCtD
Rivastigmine—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00945	CcSEcCtD
Rivastigmine—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00919	CcSEcCtD
Rivastigmine—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00919	CcSEcCtD
Rivastigmine—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00848	CcSEcCtD
Rivastigmine—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00827	CcSEcCtD
Rivastigmine—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00827	CcSEcCtD
Rivastigmine—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00827	CcSEcCtD
Rivastigmine—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00817	CcSEcCtD
Rivastigmine—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00817	CcSEcCtD
Rivastigmine—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00807	CcSEcCtD
Rivastigmine—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.000995	0.00798	CcSEcCtD
Rivastigmine—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.000973	0.0078	CcSEcCtD
Rivastigmine—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.000962	0.00771	CcSEcCtD
Rivastigmine—ACHE—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.000956	0.0524	CbGpPWpGaD
Rivastigmine—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.000951	0.00762	CcSEcCtD
Rivastigmine—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.000941	0.00754	CcSEcCtD
Rivastigmine—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.000892	0.00715	CcSEcCtD
Rivastigmine—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.000883	0.00708	CcSEcCtD
Rivastigmine—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000883	0.00708	CcSEcCtD
Rivastigmine—ACHE—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000875	0.048	CbGpPWpGaD
Rivastigmine—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.000857	0.00687	CcSEcCtD
Rivastigmine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.000849	0.0068	CcSEcCtD
Rivastigmine—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000849	0.0068	CcSEcCtD
Rivastigmine—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.000849	0.0068	CcSEcCtD
Rivastigmine—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00674	CcSEcCtD
Rivastigmine—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00674	CcSEcCtD
Rivastigmine—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.000833	0.00667	CcSEcCtD
Rivastigmine—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.000825	0.00661	CcSEcCtD
Rivastigmine—Delusion—Riluzole—amyotrophic lateral sclerosis	0.000817	0.00655	CcSEcCtD
Rivastigmine—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.000817	0.00655	CcSEcCtD
Rivastigmine—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.000817	0.00655	CcSEcCtD
Rivastigmine—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00081	0.00649	CcSEcCtD
Rivastigmine—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00081	0.00649	CcSEcCtD
Rivastigmine—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.000803	0.00643	CcSEcCtD
Rivastigmine—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.000803	0.00643	CcSEcCtD
Rivastigmine—ACHE—Synthesis of PC—CHAT—amyotrophic lateral sclerosis	0.000791	0.0434	CbGpPWpGaD
Rivastigmine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.000768	0.00616	CcSEcCtD
Rivastigmine—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.000768	0.00616	CcSEcCtD
Rivastigmine—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.000755	0.00606	CcSEcCtD
Rivastigmine—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.000743	0.00596	CcSEcCtD
Rivastigmine—Abscess—Riluzole—amyotrophic lateral sclerosis	0.000731	0.00586	CcSEcCtD
Rivastigmine—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00072	0.00577	CcSEcCtD
Rivastigmine—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00072	0.00577	CcSEcCtD
Rivastigmine—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.000714	0.00572	CcSEcCtD
Rivastigmine—BCHE—Synthesis of PC—CHAT—amyotrophic lateral sclerosis	0.000706	0.0387	CbGpPWpGaD
Rivastigmine—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.000682	0.00547	CcSEcCtD
Rivastigmine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.000673	0.00539	CcSEcCtD
Rivastigmine—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.000663	0.00531	CcSEcCtD
Rivastigmine—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.000645	0.00517	CcSEcCtD
Rivastigmine—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.000641	0.00513	CcSEcCtD
Rivastigmine—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.000636	0.0051	CcSEcCtD
Rivastigmine—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.000636	0.0051	CcSEcCtD
Rivastigmine—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.000628	0.00503	CcSEcCtD
Rivastigmine—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.000624	0.005	CcSEcCtD
Rivastigmine—Gout—Riluzole—amyotrophic lateral sclerosis	0.00062	0.00497	CcSEcCtD
Rivastigmine—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.000616	0.00493	CcSEcCtD
Rivastigmine—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.000612	0.0049	CcSEcCtD
Rivastigmine—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.000612	0.0049	CcSEcCtD
Rivastigmine—Cataract—Riluzole—amyotrophic lateral sclerosis	0.000608	0.00487	CcSEcCtD
Rivastigmine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.000593	0.00475	CcSEcCtD
Rivastigmine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.000589	0.00472	CcSEcCtD
Rivastigmine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.000589	0.00472	CcSEcCtD
Rivastigmine—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.000579	0.00464	CcSEcCtD
Rivastigmine—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.000579	0.00464	CcSEcCtD
Rivastigmine—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.000579	0.00464	CcSEcCtD
Rivastigmine—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.000572	0.00458	CcSEcCtD
Rivastigmine—Melaena—Riluzole—amyotrophic lateral sclerosis	0.000565	0.00453	CcSEcCtD
Rivastigmine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.000559	0.00448	CcSEcCtD
Rivastigmine—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.000552	0.00443	CcSEcCtD
Rivastigmine—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.000549	0.0044	CcSEcCtD
Rivastigmine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.000531	0.00426	CcSEcCtD
Rivastigmine—Coma—Riluzole—amyotrophic lateral sclerosis	0.000529	0.00424	CcSEcCtD
Rivastigmine—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.000523	0.00419	CcSEcCtD
Rivastigmine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.000515	0.00413	CcSEcCtD
Rivastigmine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.000507	0.00406	CcSEcCtD
Rivastigmine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.000502	0.00402	CcSEcCtD
Rivastigmine—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.000502	0.00402	CcSEcCtD
Rivastigmine—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.000492	0.00395	CcSEcCtD
Rivastigmine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.000492	0.00395	CcSEcCtD
Rivastigmine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.000487	0.00391	CcSEcCtD
Rivastigmine—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.000483	0.00387	CcSEcCtD
Rivastigmine—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.000483	0.00387	CcSEcCtD
Rivastigmine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.000469	0.00376	CcSEcCtD
Rivastigmine—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.000469	0.00376	CcSEcCtD
Rivastigmine—Eczema—Riluzole—amyotrophic lateral sclerosis	0.000467	0.00375	CcSEcCtD
Rivastigmine—ACHE—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.000465	0.0255	CbGpPWpGaD
Rivastigmine—Injury—Riluzole—amyotrophic lateral sclerosis	0.000457	0.00366	CcSEcCtD
Rivastigmine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.000453	0.00363	CcSEcCtD
Rivastigmine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.000447	0.00358	CcSEcCtD
Rivastigmine—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000447	0.00358	CcSEcCtD
Rivastigmine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.000443	0.00355	CcSEcCtD
Rivastigmine—Thirst—Riluzole—amyotrophic lateral sclerosis	0.000441	0.00354	CcSEcCtD
Rivastigmine—Purpura—Riluzole—amyotrophic lateral sclerosis	0.000436	0.00349	CcSEcCtD
Rivastigmine—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000432	0.00346	CcSEcCtD
Rivastigmine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00043	0.00345	CcSEcCtD
Rivastigmine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.000422	0.00338	CcSEcCtD
Rivastigmine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00042	0.00337	CcSEcCtD
Rivastigmine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00042	0.00337	CcSEcCtD
Rivastigmine—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00042	0.00337	CcSEcCtD
Rivastigmine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.000417	0.00334	CcSEcCtD
Rivastigmine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000413	0.00331	CcSEcCtD
Rivastigmine—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000413	0.00331	CcSEcCtD
Rivastigmine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00041	0.00329	CcSEcCtD
Rivastigmine—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.000405	0.00325	CcSEcCtD
Rivastigmine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.000399	0.0032	CcSEcCtD
Rivastigmine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000399	0.0032	CcSEcCtD
Rivastigmine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000398	0.00319	CcSEcCtD
Rivastigmine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.000395	0.00317	CcSEcCtD
Rivastigmine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000391	0.00313	CcSEcCtD
Rivastigmine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000388	0.00311	CcSEcCtD
Rivastigmine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.000384	0.00307	CcSEcCtD
Rivastigmine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000382	0.00306	CcSEcCtD
Rivastigmine—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00038	0.00304	CcSEcCtD
Rivastigmine—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000372	0.00298	CcSEcCtD
Rivastigmine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00037	0.00297	CcSEcCtD
Rivastigmine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000363	0.00291	CcSEcCtD
Rivastigmine—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000359	0.0197	CbGpPWpGaD
Rivastigmine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000356	0.00285	CcSEcCtD
Rivastigmine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.000354	0.00283	CcSEcCtD
Rivastigmine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000349	0.0028	CcSEcCtD
Rivastigmine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000339	0.00272	CcSEcCtD
Rivastigmine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000335	0.00269	CcSEcCtD
Rivastigmine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.000334	0.00268	CcSEcCtD
Rivastigmine—ACHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.000332	0.0182	CbGpPWpGaD
Rivastigmine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000331	0.00266	CcSEcCtD
Rivastigmine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00033	0.00265	CcSEcCtD
Rivastigmine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000328	0.00263	CcSEcCtD
Rivastigmine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000326	0.00261	CcSEcCtD
Rivastigmine—ACHE—medulla oblongata—amyotrophic lateral sclerosis	0.000324	0.0649	CbGeAlD
Rivastigmine—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000324	0.00259	CcSEcCtD
Rivastigmine—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000324	0.00259	CcSEcCtD
Rivastigmine—Depression—Riluzole—amyotrophic lateral sclerosis	0.000323	0.00259	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000319	0.00256	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000317	0.00254	CcSEcCtD
Rivastigmine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000317	0.00254	CcSEcCtD
Rivastigmine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.000315	0.00252	CcSEcCtD
Rivastigmine—ACHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.000312	0.0171	CbGpPWpGaD
Rivastigmine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00031	0.00249	CcSEcCtD
Rivastigmine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000309	0.00247	CcSEcCtD
Rivastigmine—ACHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.000306	0.0168	CbGpPWpGaD
Rivastigmine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.000306	0.00245	CcSEcCtD
Rivastigmine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000305	0.00245	CcSEcCtD
Rivastigmine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000304	0.00243	CcSEcCtD
Rivastigmine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000296	0.00237	CcSEcCtD
Rivastigmine—BCHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.000296	0.0162	CbGpPWpGaD
Rivastigmine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000292	0.00234	CcSEcCtD
Rivastigmine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000291	0.00233	CcSEcCtD
Rivastigmine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000291	0.00233	CcSEcCtD
Rivastigmine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000291	0.00233	CcSEcCtD
Rivastigmine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.00029	0.0159	CbGpPWpGaD
Rivastigmine—ACHE—spinal cord—amyotrophic lateral sclerosis	0.000289	0.0579	CbGeAlD
Rivastigmine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000289	0.00232	CcSEcCtD
Rivastigmine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000289	0.00232	CcSEcCtD
Rivastigmine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000288	0.00231	CcSEcCtD
Rivastigmine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000287	0.0023	CcSEcCtD
Rivastigmine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000286	0.00229	CcSEcCtD
Rivastigmine—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000285	0.00229	CcSEcCtD
Rivastigmine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000285	0.00228	CcSEcCtD
Rivastigmine—BCHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.000278	0.0152	CbGpPWpGaD
Rivastigmine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.000275	0.0022	CcSEcCtD
Rivastigmine—BCHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.000273	0.015	CbGpPWpGaD
Rivastigmine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000272	0.00218	CcSEcCtD
Rivastigmine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00027	0.00216	CcSEcCtD
Rivastigmine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000264	0.0529	CbGeAlD
Rivastigmine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000264	0.00211	CcSEcCtD
Rivastigmine—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000262	0.0021	CcSEcCtD
Rivastigmine—Chills—Riluzole—amyotrophic lateral sclerosis	0.000261	0.00209	CcSEcCtD
Rivastigmine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00026	0.00208	CcSEcCtD
Rivastigmine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.000259	0.0142	CbGpPWpGaD
Rivastigmine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000257	0.00206	CcSEcCtD
Rivastigmine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000255	0.00204	CcSEcCtD
Rivastigmine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000253	0.00203	CcSEcCtD
Rivastigmine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000249	0.002	CcSEcCtD
Rivastigmine—Tension—Riluzole—amyotrophic lateral sclerosis	0.000248	0.00199	CcSEcCtD
Rivastigmine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000248	0.00199	CcSEcCtD
Rivastigmine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000246	0.00197	CcSEcCtD
Rivastigmine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000245	0.00196	CcSEcCtD
Rivastigmine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000243	0.00195	CcSEcCtD
Rivastigmine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000237	0.0019	CcSEcCtD
Rivastigmine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000235	0.00188	CcSEcCtD
Rivastigmine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000234	0.00187	CcSEcCtD
Rivastigmine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000232	0.00186	CcSEcCtD
Rivastigmine—ACHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.000232	0.0127	CbGpPWpGaD
Rivastigmine—ACHE—cerebellum—amyotrophic lateral sclerosis	0.000229	0.0459	CbGeAlD
Rivastigmine—ACHE—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000229	0.0126	CbGpPWpGaD
Rivastigmine—BCHE—brainstem—amyotrophic lateral sclerosis	0.000229	0.0457	CbGeAlD
Rivastigmine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000228	0.00183	CcSEcCtD
Rivastigmine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000227	0.00182	CcSEcCtD
Rivastigmine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000227	0.00182	CcSEcCtD
Rivastigmine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000224	0.00179	CcSEcCtD
Rivastigmine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000222	0.00178	CcSEcCtD
Rivastigmine—Cough—Riluzole—amyotrophic lateral sclerosis	0.000221	0.00177	CcSEcCtD
Rivastigmine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000219	0.00176	CcSEcCtD
Rivastigmine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000218	0.00175	CcSEcCtD
Rivastigmine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000215	0.00173	CcSEcCtD
Rivastigmine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000215	0.00173	CcSEcCtD
Rivastigmine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000215	0.00173	CcSEcCtD
Rivastigmine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000215	0.00172	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000214	0.00171	CcSEcCtD
Rivastigmine—ACHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.000214	0.0117	CbGpPWpGaD
Rivastigmine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000213	0.00171	CcSEcCtD
Rivastigmine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000211	0.00169	CcSEcCtD
Rivastigmine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000208	0.00167	CcSEcCtD
Rivastigmine—BCHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.000207	0.0113	CbGpPWpGaD
Rivastigmine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000206	0.00165	CcSEcCtD
Rivastigmine—Infection—Riluzole—amyotrophic lateral sclerosis	0.000205	0.00164	CcSEcCtD
Rivastigmine—Shock—Riluzole—amyotrophic lateral sclerosis	0.000203	0.00163	CcSEcCtD
Rivastigmine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000202	0.00162	CcSEcCtD
Rivastigmine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000202	0.00162	CcSEcCtD
Rivastigmine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000201	0.00161	CcSEcCtD
Rivastigmine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0002	0.00161	CcSEcCtD
Rivastigmine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0002	0.0016	CcSEcCtD
Rivastigmine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000197	0.00158	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000194	0.0106	CbGpPWpGaD
Rivastigmine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000193	0.00155	CcSEcCtD
Rivastigmine—BCHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.000191	0.0104	CbGpPWpGaD
Rivastigmine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000188	0.00151	CcSEcCtD
Rivastigmine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000187	0.0015	CcSEcCtD
Rivastigmine—ACHE—brain—amyotrophic lateral sclerosis	0.000186	0.0373	CbGeAlD
Rivastigmine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000185	0.00149	CcSEcCtD
Rivastigmine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000184	0.00147	CcSEcCtD
Rivastigmine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000183	0.00147	CcSEcCtD
Rivastigmine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000182	0.00146	CcSEcCtD
Rivastigmine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000179	0.00144	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000178	0.00143	CcSEcCtD
Rivastigmine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000178	0.00143	CcSEcCtD
Rivastigmine—Pain—Riluzole—amyotrophic lateral sclerosis	0.000177	0.00141	CcSEcCtD
Rivastigmine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000177	0.00141	CcSEcCtD
Rivastigmine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00017	0.00136	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000169	0.00135	CcSEcCtD
Rivastigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000168	0.00923	CbGpPWpGaD
Rivastigmine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000164	0.00131	CcSEcCtD
Rivastigmine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000163	0.00131	CcSEcCtD
Rivastigmine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000163	0.00131	CcSEcCtD
Rivastigmine—ACHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.000162	0.00887	CbGpPWpGaD
Rivastigmine—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.000159	0.0319	CbGeAlD
Rivastigmine—ACHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000159	0.0087	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000158	0.00866	CbGpPWpGaD
Rivastigmine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000152	0.00122	CcSEcCtD
Rivastigmine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000151	0.0303	CbGeAlD
Rivastigmine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000148	0.00119	CcSEcCtD
Rivastigmine—ACHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000147	0.00803	CbGpPWpGaD
Rivastigmine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000146	0.00117	CcSEcCtD
Rivastigmine—BCHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.000144	0.00792	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000143	0.00784	CbGpPWpGaD
Rivastigmine—BCHE—spinal cord—amyotrophic lateral sclerosis	0.000142	0.0284	CbGeAlD
Rivastigmine—BCHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000142	0.00776	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000142	0.00776	CbGpPWpGaD
Rivastigmine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000141	0.00113	CcSEcCtD
Rivastigmine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000136	0.00109	CcSEcCtD
Rivastigmine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000131	0.00105	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000131	0.00716	CbGpPWpGaD
Rivastigmine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00013	0.00104	CcSEcCtD
Rivastigmine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00013	0.00104	CcSEcCtD
Rivastigmine—ACHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000129	0.00709	CbGpPWpGaD
Rivastigmine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000129	0.00104	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000128	0.007	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000126	0.00692	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000126	0.00688	CbGpPWpGaD
Rivastigmine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000123	0.000983	CcSEcCtD
Rivastigmine—ACHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000122	0.00667	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00012	0.00659	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00012	0.00659	CbGpPWpGaD
Rivastigmine—BCHE—nervous system—amyotrophic lateral sclerosis	0.00012	0.024	CbGeAlD
Rivastigmine—BCHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000115	0.00633	CbGpPWpGaD
Rivastigmine—BCHE—central nervous system—amyotrophic lateral sclerosis	0.000115	0.0231	CbGeAlD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000115	0.00629	CbGpPWpGaD
Rivastigmine—ACHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.000115	0.00628	CbGpPWpGaD
Rivastigmine—BCHE—cerebellum—amyotrophic lateral sclerosis	0.000113	0.0226	CbGeAlD
Rivastigmine—ACHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000112	0.00615	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000112	0.00614	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000109	0.00595	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000109	0.00595	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000108	0.00595	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000108	0.00594	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000107	0.00588	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000107	0.00588	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000107	0.00588	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000107	0.00585	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000105	0.00578	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000102	0.00561	CbGpPWpGaD
Rivastigmine—BCHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.000102	0.0056	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.0001	0.0055	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0001	0.00549	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	9.92e-05	0.00544	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	9.92e-05	0.00544	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	9.92e-05	0.00543	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	9.68e-05	0.0053	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	9.67e-05	0.0053	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	9.57e-05	0.00524	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	9.52e-05	0.00522	CbGpPWpGaD
Rivastigmine—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	9.4e-05	0.00515	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	9.22e-05	0.00505	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	9.22e-05	0.00505	CbGpPWpGaD
Rivastigmine—BCHE—brain—amyotrophic lateral sclerosis	9.15e-05	0.0183	CbGeAlD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	8.95e-05	0.00491	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	8.85e-05	0.00485	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	8.85e-05	0.00485	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	8.22e-05	0.00451	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	8.22e-05	0.00451	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	8.22e-05	0.00451	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	8.22e-05	0.0045	CbGpPWpGaD
Rivastigmine—CYP3A4—nervous system—amyotrophic lateral sclerosis	8.06e-05	0.0161	CbGeAlD
Rivastigmine—ACHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	8.01e-05	0.00439	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	8e-05	0.00438	CbGpPWpGaD
Rivastigmine—CYP2D6—nervous system—amyotrophic lateral sclerosis	7.93e-05	0.0159	CbGeAlD
Rivastigmine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	7.76e-05	0.0155	CbGeAlD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	7.66e-05	0.0042	CbGpPWpGaD
Rivastigmine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	7.64e-05	0.0153	CbGeAlD
Rivastigmine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	7.47e-05	0.0149	CbGeAlD
Rivastigmine—BCHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	7.33e-05	0.00402	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	7.33e-05	0.00402	CbGpPWpGaD
Rivastigmine—BCHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	7.15e-05	0.00392	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.13e-05	0.00391	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.88e-05	0.00377	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	6.77e-05	0.00371	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.69e-05	0.00367	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	6.46e-05	0.00354	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	6.17e-05	0.00338	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	6.14e-05	0.00336	CbGpPWpGaD
Rivastigmine—CYP2D6—brain—amyotrophic lateral sclerosis	6.06e-05	0.0121	CbGeAlD
Rivastigmine—BCHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	6.04e-05	0.00331	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	5.7e-05	0.00312	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—VAPB—amyotrophic lateral sclerosis	5.59e-05	0.00306	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TPK1—amyotrophic lateral sclerosis	5.59e-05	0.00306	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.21e-05	0.00286	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—VAPA—amyotrophic lateral sclerosis	5.11e-05	0.0028	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	5.08e-05	0.00279	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—VAPB—amyotrophic lateral sclerosis	4.99e-05	0.00273	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TPK1—amyotrophic lateral sclerosis	4.99e-05	0.00273	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	4.85e-05	0.00266	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.75e-05	0.00261	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.65e-05	0.00255	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—VAPA—amyotrophic lateral sclerosis	4.56e-05	0.0025	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—FIG4—amyotrophic lateral sclerosis	4.47e-05	0.00245	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.37e-05	0.0024	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	4.32e-05	0.00237	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.24e-05	0.00232	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	4.19e-05	0.0023	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—DAO—amyotrophic lateral sclerosis	4.04e-05	0.00222	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—FIG4—amyotrophic lateral sclerosis	3.99e-05	0.00219	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—DAO—amyotrophic lateral sclerosis	3.61e-05	0.00198	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	3.58e-05	0.00196	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	3.48e-05	0.00191	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	3.23e-05	0.00177	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	3.19e-05	0.00175	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PLB1—amyotrophic lateral sclerosis	3.06e-05	0.00168	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.99e-05	0.00164	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.95e-05	0.00162	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSR—amyotrophic lateral sclerosis	2.83e-05	0.00155	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.74e-05	0.0015	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PLB1—amyotrophic lateral sclerosis	2.73e-05	0.0015	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.57e-05	0.00141	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSR—amyotrophic lateral sclerosis	2.52e-05	0.00138	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CHAT—amyotrophic lateral sclerosis	2.32e-05	0.00127	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.3e-05	0.00126	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.29e-05	0.00126	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.29e-05	0.00126	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.12e-05	0.00116	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.1e-05	0.00115	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CHAT—amyotrophic lateral sclerosis	2.07e-05	0.00114	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.07e-05	0.00113	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.96e-05	0.00107	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.95e-05	0.00107	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.93e-05	0.00106	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.89e-05	0.00104	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.83e-05	0.001	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.66e-05	0.000909	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.51e-05	0.000829	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.5e-05	0.000822	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.5e-05	0.000822	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.45e-05	0.000796	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.37e-05	0.000752	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	1.35e-05	0.00074	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.29e-05	0.00071	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.27e-05	0.000699	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.26e-05	0.000689	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.25e-05	0.000684	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.2e-05	0.000657	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.16e-05	0.000636	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	0.000628	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.11e-05	0.00061	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.08e-05	0.000594	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.02e-05	0.000561	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	9.52e-06	0.000522	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—APOE—amyotrophic lateral sclerosis	9.43e-06	0.000517	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—APOE—amyotrophic lateral sclerosis	8.42e-06	0.000461	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	8.22e-06	0.00045	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	7.58e-06	0.000416	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.46e-06	0.000354	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	6.23e-06	0.000341	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.77e-06	0.000316	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.12e-06	0.00028	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.7e-06	0.000258	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.87e-06	0.000212	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.35e-06	0.000183	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.07e-06	0.000169	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.65e-06	0.000145	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.53e-06	0.000139	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.73e-06	9.5e-05	CbGpPWpGaD
